CrossrefInformační karta
The inhibitory effect of an EGF receptor-specific tyrosine kinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF I
International journal of pancreatology · 1998-10 · 24 (2) · 85-95
DOI: 10.1007/bf02788565 ↗Abstrakt
Není k dispozici žádný abstrakt.
EUVIMED